Skip to search formSkip to main contentSkip to account menu

otilonium bromide

Known as: N-diethylmethylammoniummethyl-p-(2-(N-octyloxy)benzoyl)aminobenzoate bromide, octylonium bromide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Aliment Pharmacol Ther 2011; 34: 432–442 
2010
2010
Antispasmodics are used clinically to treat a variety of gastrointestinal disorders by inhibition of smooth muscle contraction… 
Highly Cited
2005
Highly Cited
2005
This study was undertaken to evaluate (1) the colonic response to eating for a prolonged time in healthy subjects and patients… 
Highly Cited
2004
Highly Cited
2004
To evaluate therapies available for the treatment of irritable bowel syndrome, and provide consensus recommendations for their… 
2004
2004
Abstract  The aim of this study is to evaluate in vitro the effect of otilonium bromide (OB) on the mechanical and electrical… 
Highly Cited
2002
Highly Cited
2002
Background/objective In order to follow the most recent developments and recommendations in trial methodology for drug evaluation… 
Review
1999
Review
1999
  • S. Evangelista
  • The Journal of international medical research
  • 1999
  • Corpus ID: 21874527
Experimental studies have shown that otilonium bromide (OB) inhibits both baseline and chemically or physically stimulated… 
Highly Cited
1998
Highly Cited
1998
To evaluate the efficacy of otilonium bromide, a spasmolytic agent, in the treatment of irritable bowel syndrome using modern and… 
1998
1998
The interaction of Otilonium bromide (OB) with binding sites for 63 different receptors and ion channels in appropriate…